SCHEMBL17875879

SCHEMBL17875879

c1ccc2c(c1)oc1ccc(-c3ccc4c(c3)-c3cc(-n5c6ccccc6c6ccccc65)ccc3COC4)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.35
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 2/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
AHR P35869 2/20 0.33
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
CHEK2 O96017 1/20 0.32
CASP3 P42574 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875815 0.94 SMN1; SMN2 (0.33) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17875837 0.94 SMN1; SMN2 (0.33) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17875881 0.93 NPC1 (0.38) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17877725 0.89 TNKS (0.34)
SCHEMBL17875772 0.88 SMN1; SMN2 (0.34) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17875813 0.87 NPC1 (0.36) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17875832 0.87 NPC1 (0.36) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17875901 0.87 MAPT (0.45) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17876285 0.86 KDM4E (0.36) NPC1KDM4ESMN1; SMN2RAB9AMAPT
SCHEMBL17875982 0.86 SMN1; SMN2 (0.35) NPC1KDM4ESMN1; SMN2RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 NPC1 2673/4885KDM4E 3120/4885SMN1; SMN2 3237/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 NPC1 2673/4885KDM4E 3120/4885SMN1; SMN2 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.